Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 4,493 | 5,008 | 34,754 | 2,027 | -14,129 |
| Operating Income | -4,493 | -5,008 | -34,754 | -2,027 | 14,120 |
| Other Income | -83 | -92 | -7 | -23 | 215 |
| Pre-tax Income | -4,576 | -5,100 | -34,761 | -2,050 | 14,335 |
| Net Income Continuous | -4,576 | -5,100 | -34,761 | -2,050 | 14,335 |
| Net Income | $-4,576 | $-5,100 | $-34,761 | $-2,050 | $14,335 |
| EPS Basic Total Ops | 115.50 | -11.25 | -238.00 | -24.25 | 244.86 |
| EPS Basic Continuous Ops | 115.76 | -11.37 | -238.09 | -24.22 | 245.31 |
| EPS Diluted Total Ops | 115.50 | -11.25 | -238.00 | -24.25 | 244.86 |
| EPS Diluted Continuous Ops | 115.76 | -11.37 | -238.09 | -24.22 | 245.31 |
| EBITDA(a) | $-4,479 | $-4,995 | $-34,740 | $-2,014 | $14,129 |